One of the key factors of this pediatric LS dataset is the lack of TGFβ expression in DEGs between different disease activities and subtypes, which may indicate that TGFβ is not the driving pediatric localized scleroderma fibrosis like it is in SSc skin. This evidence concerns the gene TGFB1 and systemic sclerosis.